Evidence map›Paper›PMID 35745286›Full record

ArticleNanomaterials (Basel, Switzerland)2022

In Vitro High-Throughput Toxicological Assessment of Nanoplastics.

Valentina Tolardo, Davide Magrì, Francesco Fumagalli, Domenico Cassano, Athanassia Athanassiou, Despina Fragouli, Sabrina Gioria

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Valentina TolardoSmart Materials, Istituto Italiano di Tecnologia, Via Morego, 30, 16163 Genova, Italy.
Davide MagrìEuropean Commission, Joint Research Centre (JRC), 21027 Ispra, Italy.
Francesco FumagalliEuropean Commission, Joint Research Centre (JRC), 21027 Ispra, Italy.
Domenico CassanoEuropean Commission, Joint Research Centre (JRC), 21027 Ispra, Italy.ORCID 0000-0002-3394-3393
Athanassia AthanassiouSmart Materials, Istituto Italiano di Tecnologia, Via Morego, 30, 16163 Genova, Italy.ORCID 0000-0002-6533-3231
Despina FragouliSmart Materials, Istituto Italiano di Tecnologia, Via Morego, 30, 16163 Genova, Italy.ORCID 0000-0002-2492-5134
Sabrina GioriaEuropean Commission, Joint Research Centre (JRC), 21027 Ispra, Italy.ORCID 0000-0001-7150-9523

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sub-micrometer particles derived from the fragmentation of plastics in the environment can enter the food chain and reach humans, posing significant health risks. To date, there is a lack of adequate toxicological assessment of the effects of nanoplastics (NPs) in mammalian systems, particularly in humans. In this work, we evaluated the potential toxic effects of three different NPs in vitro: two NPs obtained by laser ablation (polycarbonate (PC) and polyethylene terephthalate (PET1)) and one (PET2) produced by nanoprecipitation. The physicochemical characterization of the NPs showed a smaller size, a larger size distribution, and a higher degree of surface oxidation for the particles produced by laser ablation. Toxicological evaluation performed on human cell line models (HePG2 and Caco-2) showed a higher toxic effect for the particles synthesized by laser ablation, with PC more toxic than PET. Interestingly, on differentiated Caco-2 cells, a conventional intestinal barrier model, none of the NPs produced toxic effects. This work wants to contribute to increase knowledge on the potential risks posed by NPs.

Indexed as

cytotoxicityhigh content screeningin vitro assayslaser ablationnanoplasticsnanotoxicologypolycarbonatepolyethylene terephthalate

Identifiers

PMID35745286
PMCPMC9230863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.